European Pharmaceutical Review

MARCH 27, 2023

percent between 2022 and 2027. Microbiology article: Pharmaceutical microbiology: key developments 2022… The post Rapid microbiology testing market growth expected 2022 to 2027 appeared first on European Pharmaceutical Review. According to the data, the market is forecasted to increase by $2,487.91 Don Whitley Scientific Ltd.,

Compounding 115

Compounding Vaccines 115

The Pharmacist

JUNE 11, 2024

The Conservative Party has set out spending plans of £250m each year on Pharmacy First from 2027 to 2030, as it pledges to expand the service to include more conditions like acne and chest infections.

Documentation 89

Documentation 89

STAT

DECEMBER 13, 2024

The nonprofit Howard Hughes Medical Institute (HHMI) will bar institutions that already have two or more beneficiaries of its Investigator Program from applying for a round of funds to be awarded in 2027.

271

271

European Pharmaceutical Review

DECEMBER 9, 2022

billion by 2027 during the forecast period, due to the rise in ongoing clinical trials for oligonucleotide-based therapies in key therapeutic sectors such as oncology. billion by 2027 appeared first on European Pharmaceutical Review. The research projected a compound annual growth rate (CAGR) of 16.8 percent from $7.7 billion in 2022.

Compounding 98

Compounding 98

European Pharmaceutical Review

FEBRUARY 1, 2023

billion in 2027 at a compound annual growth rate (CAGR) of 12.5 The post Pharmaceutical sterility testing market to grow from $2.07b in 2027 appeared first on European Pharmaceutical Review. A recent market report showed that the global pharmaceutical sterility testing market is expected to grow from $2.07 billion in 2022 to $1.29

Compounding 98

Compounding 98

STAT

DECEMBER 7, 2023

One expires next year and the other in 2027, well beyond the original patent expiration date. The move meant that the company, which is now part of Bristol Myers Squibb, won several more years of valuable patent protection than it would have received had it applied for the extra patents when submitting its data to the FDA.

Drug Pricing 321

Drug Pricing Compounding Pharmaceutical Companies Pharmaceutical Companies 321

STAT

JULY 24, 2023

The House Ways & Means Committee package includes a new provision that would ensure that patients in the Medicare program pay for medicines they pick up at the pharmacy counter based on the discounted price that insurers negotiate with drugmakers, instead of higher sticker prices, starting in 2027.

Packaging 246

Packaging Drug Pricing Hospitals 246

STAT

JANUARY 17, 2023

The number of health care-related artificial intelligence models on the market has increased steadily over the past decade, with the health care AI market expected to grow from $7 billion today to $67 billion in 2027.

255

255

Express Pharma

NOVEMBER 25, 2024

The Government aims to expand the reach of PMBJP by increasing the number of Pradhan Mantri Bhartiya Janaushadhi Kendras (PMBJKs) to 25,000 by March 2027. The post Pharmaceuticals & Medical Devices Bureau of India participates in 43rd Edition of IITF 2024 appeared first on Express Pharma.

104

104

STAT

OCTOBER 3, 2024

1, 2025, the Centers for Medicare and Medicaid Services will select the costliest prescription medications to negotiate on, with prices coming into effect in 2027.

255

255

Express Pharma

FEBRUARY 18, 2025

per cent (2025-2030), driven by the anticipated launch of two high-priced targeted therapies for FXS in 2027, according to GlobalData. The fragile X syndrome (FXS) market across the US and Germany is projected to experience explosive growth, quadrupling from $28.7 million in 2025 to $111.9 million by 2030, a CAGR of 31.3

Labelling 99

Labelling 99

STAT

JUNE 25, 2024

The company said that it expects to add 1,000 new jobs, and that construction will gradually be finalized between 2027 and 2029. Novo Nordisk said the new facility would expand over 56 acres and add 1.4 million square feet of production space, doubling the combined square footage of the other three facilities in North Carolina.

277

277

STAT

NOVEMBER 20, 2023

Under the new agreement, the level of allowed growth in drug sales will increase from 2% in 2024 to 4% by 2027. The current plan, which has drawn the ire of pharma companies, requires drug companies to pay rebates back to the U.K. if spending on medicines increases by more than 2% a year. Continue to STAT+ to read the full story…

284

284

PharmaVoice

JULY 1, 2024

government, the latest spending projections reveal soon-to-be-implemented price caps will have an impact by 2027. As the first 10 drugs undergo price negotiations with the U.S.

130

130

The Pharmacist

FEBRUARY 20, 2025

No changes will be introduced to the Community Pharmacy England (CPE) committee membership until the current term ends in 2027, notes from the negotiator's latest meeting have confirmed. But the two non-Company Chemists' Association (CCA) 10+ multiple observers will remain as such until March 2027.

Community Pharmacies 52

Community Pharmacies 52

Express Pharma

NOVEMBER 5, 2024

million over a three-year period, ending on June 30, 2027, a filing showed. Under terms of the deal, the company and the UKHSA agreed to settle the outstanding amount under dispute related to upfront payments received by Novavax from the health agency. Novavax has agreed to refund $123.8 The first installment payment is due on Nov.

Vaccines 103

Vaccines 103

Pharmaceutical Technology

AUGUST 31, 2023

Alkermes settled the lawsuit with Teva, allowing the latter to market the generic version of Vivitrol from January 2027.

52

52

BioPharma Dive

NOVEMBER 15, 2023

The deal gives Gilead an estimated 13% ownership in Arcellx and extends the company’s cash runway into 2027.

117

117

Express Pharma

FEBRUARY 23, 2025

The institution will offer a variety of leadership programmes, ranging from short workshops to extended courses lasting 9 to 12 months, starting in March 2027. SOULs mission is to empower young individuals for roles in public sectors such as health, education, rural development, and sanitation.

Communication 101

Communication 101

Express Pharma

FEBRUARY 11, 2025

billion by 2027, driven by increasing demand for innovative patient-friendly dosage forms, said Paul Smaltz, Head of the Pharmaceutical Solutions Business Unit at Roquette. The platform provides manufacturers with ready-to-use coating premixes for pharmaceutical prescription, nutraceutical, and over-the-counter (OTC) products.

Dosage 85

Dosage 85

Express Pharma

JANUARY 2, 2025

The late-stage T1D pipeline consists of several agents, including Eli Lillys insulin efsitora alfa, which is anticipated to launch in 2027.

Diabetes 105

Diabetes Vaccines Compounding 105

pharmaphorum

FEBRUARY 6, 2025

BMS is extending its bid to cut costs by $1.5bn before the end of this year, backed by 2,200 job cuts, adding a target of another $2bn by end-2027.

93

93

Pharmaceutical Commerce

AUGUST 19, 2024

The 86,000 square-foot Køge facility will be fully functional by 2027.

81

81

Putting Patients First Blog

JULY 2, 2024

Clarification on QALY Metrics The NHC appreciates CMS’ commitment to excluding Quality-Adjusted Life Years (QALYs) from the negotiation process as outlined in the 2027 draft guidance. Valuing life differently based on disability status, age, or other special populations is inappropriate.

Drug Pricing 52

Drug Pricing Insurance Coverage and Processing Labelling HIPAA 52

Express Pharma

MARCH 2, 2025

Under PMBJP, the government has set a target to open 25000 JAKs by March 31, 2027 across the country. The product basket of PMBJP comprises 2047 drugs and 300 surgical equipment which are sold at retail shops at 50 per cent to 80 per cent cheaper than branded medicines.

Generic Medicine 76

Generic Medicine Diabetes 76

Outsourcing Pharma

OCTOBER 24, 2023

Traditionally, the pharmaceutical landscape has been dominated by small molecules.

64

64

BioPharma Dive

FEBRUARY 6, 2025

The pharmaceutical company plans to cut $2 billion in annual expenses by the end of 2027 through “operational efficiencies across multiple areas of the business,” its CFO told analysts on a conference call.

Pharmaceutical Companies 74

Pharmaceutical Companies Pharmaceutical Companies 74

The Guardian - Pharmaceutical Industry

SEPTEMBER 21, 2023

The commission’s investigation was made public last week by the health department and the Health Justice Initiative (HJI) legal organisation at a media briefing of Médecins Sans Frontières (MSF).

Drug Pricing 104

Drug Pricing 104

PharmaTech

SEPTEMBER 12, 2024

Seventeen biologics and nine tides—five peptides and four oligonucleotides—were approved in 2023 alone, with further growth predicted.

52

52

Pharmaceutical Commerce

APRIL 5, 2023

Rise in value attributed to the ongoing decentralization of pharmacies.

52

52

STAT

SEPTEMBER 12, 2024

billion, between 2024 and 2027 in a concession to investors who have viewed the company’s outlays following its pandemic-era windfall as profligate, STAT writes. So here are some items of interest. Have a great day, everyone. … Moderna plans to cut its annual spending on research and development by 23%, or $1.1

Packaging 146

Packaging Diabetes Vaccines 146

Pharmacy Times

JANUARY 10, 2023

The report highlights the growth of personalized medicines with improved efficacy for rare, previously untreatable diseases.

52

52

Putting Patients First Blog

SEPTEMBER 3, 2024

We strongly urge CMS to address these issues in the IPAY 2027 portal to ensure that all participants, regardless of their familiarity with technology or survey formats, can contribute their insights without unnecessary difficulty. Conclusion The NHC appreciates the opportunity to provide input on the IRA 2027 Drug Price Negotiation ICR.

Drug Pricing 52

Drug Pricing Insurance Coverage and Processing Labelling Communication 52

PharmaTech

OCTOBER 26, 2023

As CMOs continue to invest in cell culture capacity, some are expected to surpass top in-house companies.

52

52

European Pharmaceutical Review

NOVEMBER 2, 2022

Somewhat ambitious: Meet three percent of GDP by 2027, building on aspirations set out by the Confederation of British Industry (CBI), the European Commission (EC) and opposition political parties. The government would need to invest an extra £1 billion in R&D by 2027. Private investment would also need to rise by £0.8

Communication 98

Communication 98

Pharmaceutical Technology

OCTOBER 6, 2023

Biologics are poised to overtake innovative small molecules in terms of sales revenue by 2027, with forecast sales of $120bn.

59

59

European Pharmaceutical Review

AUGUST 27, 2024

Manufacturing of the biologic products in the expanded Sweden Biomanufacturing Center is planned to begin from Q4 of 2027, according to AstraZeneca. “We are happy about this investment in Södertälje, which demonstrates AstraZeneca’s commitment to innovation and manufacturing of biological medicines in Sweden”, Alfredsson continued.

115

115